The drugmaker struck a collaboration agreement with Mass General to use its platform for heart failure and asthma management. The health system plans to launch two pilots of the digital health platform.
Heart failure patients reported reduced depression symptoms and better self-care after receiving behavioral therapy through telehealth services, according to a small study by AbleTo and Humana.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Biofourmis's CEO boldly declared the company will become a unicorn and this acquisition is expected to give the startup access to more raw data as it expands its analytics platforms and brings Biovotion's Everion wearable armband inhouse.
Houston-based CorInnova won the medical device track for the Pitch Perfect contest at the MedCity INVEST conference in Chicago.
WhiteSwell is pitching a technology to better treat acute decompensated heart failure by finding an alternative route to decongest the fluid back-up caused by the heart's inability to pump effectively.
The company was founded last year and has developed technology that analyzes data from a combination of clinical and commercial devices to monitor and track the health status of patients at home.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A new study in the Journal of the American Heart Association found there was not an association between a hospital's degree of EHR implementation and improved quality of care and outcomes for heart failure patients.
The study out of Vanderbilt University Medical Center found 14 percent of individuals with genetic variants impacting the kidney had kidney transplants and 10 percent with another variant had liver transplants. These transplants could have been avoided had the underlying genetic cause been disclosed.
Massachusetts General Hospital is working with Jana Care to conduct a study on the company's heart failure management mobile app, called Heart Habits.
The device could be the next evolution in assistive technology, helping manage congestive heart failure more safely.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Neuromodulation is gaining ground as a therapy for reducing pain, but no one has yet harnessed it within the cardiology arena, putting the company in a unique position if the Barostim gains FDA approval and commercial success.
scPharmaceuticals has raised $3.6 million in what looks to be a bridge financing round for its drug/device combo that could replace IV use in treating heart failure and infections.
Cardionomic has secured significant funding to further develop its device designed to treat acute decompensated heart failure with electronic stimulation, a departure from traditional prescription drug treatment.
VP Donnie McGrath said at this week's RESI conference in Houston that Bristol-Myers Squibb is targeting heart failure, virology, immunoscience, rare disease and fibrosis.
When congestive heart failure patients leave hospitals, a healthcare media startup wants them to be given a parting gift at discharge: a DVD. The idea is to help patients better understand their care plan by showing them what they need to do to change their behavior and avoid becoming a rapid readmission statistic and to […]